Compliance Matters a Healthcare Compliance Newsletter December 2014 | Volume 13 Issue 4 in This Issue: October 1, 2015 ICD-10 Compliance Date Remains Firm ______2

Total Page:16

File Type:pdf, Size:1020Kb

Compliance Matters a Healthcare Compliance Newsletter December 2014 | Volume 13 Issue 4 in This Issue: October 1, 2015 ICD-10 Compliance Date Remains Firm ______2 Compliance Matters A Healthcare Compliance Newsletter December 2014 | Volume 13 Issue 4 In this issue: October 1, 2015 ICD-10 Compliance Date Remains Firm _____________________________________ 2 National Correct Coding Initiative Edits (NCCI) ___________________________________________ 3 CMS Finalizes New Safeguards to Reduce Medicare Fraud ___________________________________ 4 Medicare Administrative Contractor (MAC) Updates: Jurisdiction JJ ____________________________ 5 Preventive and Screening Services Update _______________________________________________ 5 ESRD Laboratory Services: Elimination of the 50/50 Rule April 2015 ___________________________ 6 CMS Creates New Chief Data Officer Post _______________________________________________ 7 Modified Requirements for Medicare Coverage of Ultrasound Screening for Abdominal Aortic Aneurysms (AAA) and Screening Fecal-Occult Blood Tests (FOBT) _____________________________________ 8 Testing with CMS FAQs: International Classification of Diseases, 10th Edition (ICD-10) End-to-End Testing __ 9 Payment for G0101 and Q0091 in Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) that Bill Under the All-Inclusive Rate (AIR) System _________________________________ 11 CMS 2015 Changes to HCPS Level II Codes ______________________________________________ 11 CPT® Changes for 2015 _____________________________________________________________ 12 The Compliance Matters Holiday Team __________________________________________________ 18 Happy Ho Ho Holidays! Compliance Matters and specificity of ICD-10-CM/PCS will likely assist October 1, 2015 ICD-10 in developing increasingly sophisticated electronic Compliance Date Remains coding tools that will help you more quickly select Firm codes.” Some have argued that the proliferation of ICD- On July 31, the U.S. Department of Health & 10 codes will spell the end of the superbill. But Human Services (HHS) issued a rule finalizing because most physician practices use a relatively October 1, 2015 as the compliance date for small number of diagnoses related to their healthcare providers, health plans, and healthcare specialty, they can continue to use super bills clearinghouses to implement ICD-10-CM. Although containing the most common diagnosis codes previous deadlines were moved “to allow insurance reported in their practice, and supplement with companies and others in the health care industry additional tools. time to ramp up their operations to ensure their systems and business processes are ready,” HHS Furthermore, the cost of ICD-10 implementation has dubbed further delay of ICD-10 a myth, and has been greatly exaggerated, causing widespread announced “no plans to extend the compliance discouragement from starting training. Recent date for implementation of ICD-10-CM/PCS; surveys have demonstrated costs could average therefore, covered entities should plan to complete only $3,500 per provider. the steps required to implement ICD-10-CM/PCS Additionally, as we head into 2015, the methods on October 1, 2015.” promulgated by the Coalition for ICD-10, and other ICD-10-CM implementation is inevitable for several implementation proponents should serve as a key reasons. Most significantly, the ICD-9-CM code springboard for the industry to continue pushing set currently in use contains “outdated, obsolete Congress to refuse any new delays. terms that are inconsistent with current medical practice, new technology, and preventive services,” as stated in the July 2014 press release, and lacks CMS July 31, 2014 Press Release: http://www.cms. the needed flexibility to keep up with changes. gov/Newsroom/MediaReleaseDatabase/Press- ICD-9-CM hasn’t received regular updates in releases/2014-Press-releases-items/2014-07-31.html several years. And because ICD-9 will receive no ICD-10 Myths and Facts: http://www.cms. updates beyond 2015, even non-covered entities gov/Medicare/Coding/ICD10/Downloads/ICD- are best served by the transition to ICD-10 10MythsandFacts.pdf Skipping ICD-10 and holding out for ICD-11, as some have proposed, isn’t a viable solution. As reported in FierceHealthIT, ICD-11 isn’t expected to be ready for use for at least a decade, and perhaps much longer. The American Medical Association’s Board of Trustees estimates that ICD-11 won’t be available for use in the U.S. for 20 years, and expressed reservations about skipping ICD-10, stating that such a move “is fraught with its own pitfalls and therefore, based on current information available, is not recommended.” “Just as an increase in the number of words in a dictionary doesn’t make it more difficult to use, the greater number of codes in ICD-10-CM/PCS doesn’t necessarily make it more complex to use,” CMS argues. “In fact, the greater number of codes in ICD-10-CM/PCS make it easier for you to find the right code.” As well, “the improved structure December 2014 | Volume 13 Issue 4 Page 2 Compliance Matters associated modifiers, the two procedure codes may National Correct Coding be reported together. NCCI-associated modifiers Initiative Edits (NCCI) may not be used to bypass an edit unless the criteria for use of the modifier are met. Back in 1996, the Centers for Medicare and Each active NCCI edit has a modifier indicator of Medicaid Services (CMS) developed the National 0 or 1. A modifier indicator of “0” indicates that an Correct Coding Initiative (NCCI) to promote correct edit can never be bypassed even if a modifier is coding and prevent inappropriate payment of used. In other words, the Column 2 code of the edit Medicare Part B claims. As this is an automated will be denied. A modifier indicator of “1” indicates prepayment review by CMS, the NCCI edits reduce that an edit may be bypassed with an appropriate payment error by identifying coding errors made modifier appended to the Column 1 and/or Column by providers. In 2009, 7.8 % of Medicare dollars did 2 code. not comply with one of more Medicare coverage, coding, billing or payment rules, translating into The NCCI-associated modifiers are: E1, E2, E3, E4, $24.1 billion dollars in Medicare overpayments and FA, F1, F2, F3, F4, F5, F6, F7, F8, F9, LC, LD, LT, RC, underpayments annually. RT, TA, T1, T2, T3, T4, T5, T6, T7, T8, T9, 25, 27, 58, 59, 78, 79, and 91. The NCCI edits define when two HCPCS/CPT ® procedure codes may not be reported together In January 1, 2013, additional modifiers were added except under special circumstances. CMS based to the list of NCCI-associated modifiers that will the NCCI coding policies on current coding allow an edit to be bypassed when the modifier is conventions, coding guidelines, national and local used correctly (i.e., edits with modifier indicator Medicare policies (NCDs and LCDs), and standard of “1”). These were LM (left main coronary artery), medical and surgical practice. Coding polices and RI (ramus intermedius), 24 (unrelated evaluation guidelines require that procedures are reported and management service by the same physician with the most comprehensive CPT® code that during a postoperative period), and 57 (decision describes the services performed. For example, for surgery). a coder should not report a Basic Metabolic Panel (BMP, CPT® 80047) with a Comprehensive Metabolic Panel CMP,CPT® code 80053) as all the analytes in CPT® 80047 BMP are a subset of the Comprehensive Metabolic Panel and would have been already performed as part of that procedure. Effective Jan 15, 2015, new more specific modifiers become effective (see also Compliance Matters, As a claim is processed by the Medicare contractor, Sept 2014) supplementing Modifier -59 (Distinct the system tests every pair of procedure codes to Procedural Service). determine if they comply with the NCCI edit policy. This means every code pair reported for the same • XE Separate Encounter: A Service That Is date of service for the same beneficiary by the Distinct Because It Occurred During A Separate same provider is reviewed against the NCCI-edit Encounter tables. If a pair of codes on the claim matches • XS Separate Structure: A Service That Is (“hits”) a pair in the NCCI edit table, the “Column Distinct Because It Was Performed On A Two” code of the edit pair is denied for payment. Separate Organ/Structure Using the CMP/BMP example above, in the NCCI edit tables, CPT® 80047 is the “Column Two” code • XP Separate Practitioner: A Service That and would have payment denied. Is Distinct Because It Was Performed By A Different Practitioner NCCI-associated modifiers are used to indicate the special circumstances such as when the procedures • XU Unusual Non-Overlapping Service: The Use are performed at different anatomic sites, a Of A Service That Is Distinct Because It Does separate procedure or repeat clinical diagnostic Not Overlap Usual Components Of The Main laboratory test. If an edit allows use of NCCI- Service December 2014 | Volume 13 Issue 4 Page 3 Compliance Matters These modifiers, collectively referred to as “The changes announced today are common- -X{EPSU} modifiers, define specific subsets of the sense safeguards to preserve Medicare for -59 modifier. CMS will not stop recognizing the -59 generations to come, while making the rules modifier but notes that CPT instructions state that more consistent for all providers that work the -59 modifier should not be used when a more with us,” Administrator Tavenner said. “The descriptive modifier is available. CMS will continue Administration is committed to using all to recognize the -59 modifier in many instances appropriate tools as part of its comprehensive but
Recommended publications
  • Reimbursement Information for Diagnostic Elastography1
    Reimbursement Information for Diagnostic Elastography1 August 2017 gehealthcare.com/reimbursement This Advisory addresses Medicare coding and payment information for diagnostic ultrasound and associated tissue elastography measurements for hospital outpatient and physician office sites of service. Although information in the Advisory reflects Medicare policies, it may also be applicable to certain private payer reimbursement policies within the United States.2, 3 Current Procedural Terminology (CPT) ACR Coding Guidance American College of Radiology (ACR) has provided coding Coding, Definitions and Medicare guidance for the two elastography CPT codes 91200 and Payment Rates 0346T in their 2017 Ultrasound Coding Users Guide.4 The recommendations for reporting procedures are as follows: Overview • CPT code 91200 should be reported for mechanically induced Tissue stiffness is often related to suspicious abnormalities or shear wave technique without imaging for liver studies. Per underlying disease. Using sensitive measurement techniques the 2017 update, code 91200 can be used for all forms of such as elastography, tissue stiffness can be accurately quantified shear wave liver elastography, including both those using and stiffness changes assessed over time to better inform mechanical (transient elastography – Fibroscan®) or acoustic physician diagnoses. (ARFI) techniques to generate the shear waves. The shear wave The American Medical Association (AMA) has created two CPT speed can be reported in meters/second (m/s) or converted codes to describe
    [Show full text]
  • Endoscopic Ultrasound for the Diagnosis of Disease and Staging of Cancers in Adult Patients with Gastroenterological Or Oncological Disease: Guidelines
    TITLE: Endoscopic Ultrasound for the Diagnosis of Disease and Staging of Cancers in Adult Patients with Gastroenterological or Oncological Disease: Guidelines DATE: 26 February 2014 RESEARCH QUESTION What are the evidence-based guidelines for the use of endoscopic ultrasound in the diagnosis of disease and staging of cancers in adult patient with gastroenterological or oncological disease? KEY MESSAGE Thirteen evidence-based guidelines regarding the use of endoscopic ultrasound in the diagnosis of disease and staging of cancers in adult patient with gastroenterological or oncological disease were identified. METHODS A limited literature search was conducted on key resources including PubMed, The Cochrane Library (2014, Issue 2), University of York Centre for Reviews and Dissemination (CRD) databases, Canadian and major international health technology agencies, as well as a focused Internet search. Methodological filters were applied to limit retrieval to guidelines. The search was also limited to English language documents published between January 1, 2009 and February 11, 2014. Internet links were provided, where available. The summary of findings was prepared from the abstracts of the relevant information. Please note that data contained in abstracts may not always be an accurate reflection of the data contained within the full article. RESULTS Thirteen evidence-based guidelines regarding the staging and diagnosis of cancer and of gastrointestinal diseases were identified. Additional references of potential interest are provided in the appendix. Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews.
    [Show full text]
  • Computing in Cardiology
    COMPUTING IN CARDIOLOGY September 13-16, 2020 Rimini, Italy Table of Contents Sponsors 3 Welcome to CinC@Rimini in 2020! 5 Board of Directors 7 Local Organizing Committee 8 Letter from the President 9 Welcome to Brno for CinC 2021 10 Maps 11 General Map of Rimini 11 Transportation, Hotels and Practical Information 14 Transportation 14 By air 14 By car 14 By train 14 Local Transportation in Rimini 15 By bus 15 By bike 15 Practical Information 16 Climate 16 Money/currency 16 Emergency phone numbers 16 Electric standards 16 Language 17 Time Zones 17 Mobile Phones 17 Safety and Security 17 COVID-19 emergency – Main general rules in Emilia - Romagna 17 COVID-19 emergency – Safety rules and procedures at Palacongressi 18 Internet Access 19 Computing in Cardiology 2020 1 Meals 20 Accompanying Persons (Guests) 20 Conference Information 21 General Information 21 Sunday Symposium 21 Programme outline 21 Conference site 22 Monday Social Program 23 Activist program 23 Passivist program 24 For Authors and Speakers 25 Oral presentations 25 IN PERSON oral presentations 25 REMOTE oral presentations 26 Q&A during oral presentations 26 Poster presentations 26 IN PERSON poster session 26 REMOTE poster session 27 Rosanna Degani Young Investigator Award 28 Clinical Needs Translational (CTA) Award 28 PhysioNet/Computing in Cardiology Challenge 2020 28 Maastricht Simulation Award (MSA) 29 Deadlines 29 Manuscripts 29 Scientific Program Details 31 Program Overview 2 Computing in Cardiology 2020 Sponsors Computing in Cardiology 2020 is supported by several institutions, companies and academic partnerships. The Local Organizing Committee would like to thank the following partners: Computing in Cardiology 2020 3 4 Computing in Cardiology 2020 Welcome to CinC@Rimini in 2020! Dear Colleagues and Friends, On behalf of the Local Organizing Committee, we warmly welcome you to Computing in Cardiology 2020.
    [Show full text]
  • Clinical Guideline Experimental Or Investigational Services
    Clinical Guideline Guideline Number: CG012, Ver. 6 Experimental or Investigational Services Disclaimer Clinical guidelines are developed and adopted to establish evidence-based clinical criteria for utilization management decisions. Oscar may delegate utilization management decisions of certain services to third-party delegates, who may develop and adopt their own clinical criteria. Clinical guidelines are applicable to certain plans. Clinical guidelines are applicable to members enrolled in Medicare Advantage plans only if there are no criteria established for the specified service in a Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) or local coverage determination (LCD) on the date of a prior authorization request. Services are subject to the terms, conditions, limitations of a member’s policy and applicable state and federal law. Please reference the member’s policy documents (e.g., Certificate/Evidence of Coverage, Schedule of Benefits) or contact Oscar at 855-672-2755 to confirm coverage and benefit conditions. Summary The services referenced in this Clinical Guideline are considered experimental or investigational and are therefore not covered by Oscar. The services referenced in this Clinical Guideline may not be all- inclusive. Specific benefit plan documents (e.g., Certificate of Coverage, Schedule of Benefits) and federal or state mandated health benefits and laws take precedence over this Clinical Guideline. A service considered experimental or investigational when its safety and efficacy has been established. They may have outcomes that are inferior to standard medical treatment, for which long-term clinical utility has been established. To determine whether a service, device, treatment or procedure has proven safety and efficacy, the available reliable evidence is reviewed, which may include but is not limited to (listed in order of decreasing reliability): 1.
    [Show full text]
  • Three-Way Comparative Study of Endoscopic Ultrasound-Guided
    Surgical Endoscopy (2019) 33:1260–1270 and Other Interventional Techniques https://doi.org/10.1007/s00464-018-6406-7 Three-way comparative study of endoscopic ultrasound-guided transmural gallbladder drainage using lumen-apposing metal stents versus endoscopic transpapillary drainage versus percutaneous cholecystostomy for gallbladder drainage in high-risk surgical patients with acute cholecystitis: clinical outcomes and success in an International, Multicenter Study Ali Siddiqui1 · Rastislav Kunda3 · Amy Tyberg2 · Mustafa A. Arain4 · Arish Noor1 · Tayebah Mumtaz1 · Usama Iqbal1 · David E. Loren1 · Thomas E. Kowalski1 · Douglas G. Adler5 · Monica Saumoy2 · Monica Gaidhane2 · Shawn Mallery4 · Eric M. Christiansen4 · Jose Nieto6 · Michel Kahaleh2 Received: 9 November 2017 / Accepted: 24 August 2018 / Published online: 12 September 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Background Percutaneous cholecystostomy tube (PTGBD), endoscopic retrograde cholangiopancreatography with trans- papillary gallbladder drainage (TP), and endoscopic ultrasound-guided transmural gallbladder drainage (EGBD) using lumen-apposing metal stents (LAMS) have been offered for gallbladder decompression for acute cholecystitis in high-risk surgical patients. Yet, there are limited data comparing these therapies. Our aim was to compare the safety and efficacy of EGBD to TP and PTGBD for gallbladder drainage. Methods We retrospectively collected high-risk surgical patients from six centers with acute cholecystitis who underwent gallbladder drainage by EGBD, TP, or PTGBD. Data included technical success (gallbladder drainage), clinical success (acute cholecystitis resolution), adverse events (AE), and follow-up. Results From 2010 to 2016, 372 patients underwent gallbladder drainage, with 146 by PTGBD, 124 by TP, and 102 drained by EGBD. Technical (98% vs. 88% vs. 94%; p = 0.004) and Clinical (97% vs.
    [Show full text]
  • Advanced Ultrasound Technologies for Diagnosis and Therapy
    Journal of Nuclear Medicine, published on March 1, 2018 as doi:10.2967/jnumed.117.200030 1 Advanced Ultrasound Technologies for Diagnosis and Therapy Anne Rix1, Wiltrud Lederle1, Benjamin Theek1, Twan Lammers1,2, Chrit Moonen3, Georg Schmitz4, Fabian Kiessling1* 1Institute for Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany 2Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands 3Imaging Division, University Medical Center Utrecht, Utrecht, The Netherland 4Department of Medical Engineering, Ruhr-University Bochum, Bochum, Germany * Corresponding author: Fabian Kiessling MD, Institute for Experimental Molecular Imaging, University Aachen (RWTH), Forckenbeckstrasse 55, 52074 Aachen, Germany. Phone:+49-241- 8080116; fax:+49-241-8082442; e-mail: [email protected] First author: Anne Rix B.Sc., Institute for Experimental Molecular Imaging, University Aachen (RWTH), Forckenbeckstrasse 55, 52074 Aachen, Germany. Phone:+49-241-8080839; fax:+49- 241-8082442; e-mail: [email protected] Running title Advanced Ultrasound Imaging and Therapy 1 2 ABSTRACT Ultrasound is among the most rapidly advancing imaging techniques. Functional methods such as elastography have been clinically introduced, and tissue characterization is improved by contrast- enhanced scans. Here, novel super-resolution techniques provide unique morphological and functional insights into tissue vascularisation. Functional analyses are complemented with molecular ultrasound imaging, to visualize markers of inflammation and angiogenesis. The full potential of diagnostic ultrasound may become apparent by integrating these multiple imaging features in radiomics approaches. Emerging interest in ultrasound also results from its therapeutic potential. Various applications on tumor ablation with high intensity focused ultrasound (HIFU) are clinically evaluated and its performance strongly benefits from the integration into Magnetic Resonance Imaging (MRI).
    [Show full text]
  • Impact of Preoperative Endoscopic Ultrasound in Surgical Oncology
    REVIEW Impact of preoperative endoscopic ultrasound in surgical oncology Endoscopic ultrasound (EUS) has a strong impact on the imaging and staging of solid tumors within or in close proximity of the upper GI tract. Technological developments during the last two decades have increased the image quality and allowed very detailed visualization of local tumor spread and lymph node affection. Current indications for EUS of the upper GI tract encompass the differentiation between benign and malignant lesions, the staging of esophageal, gastric and pancreatic cancer, and the procurement of a biopsy specimen through fine-needle aspiration. Various technical innovations during the past two decades have increased the diagnostic quality and have simultaneously strengthened the role of EUS in the clinical setting. This article will give a compressed summary on the current state of EUS and possible further technical developments. 1 KEYWORDS: 3D imaging elastosonography endoscopic ultrasound miniprobes Sascha S Chopra & oncologic surgery Michael Hünerbein† 1Department of General & Transplantation Surgery, Charité Campus Virchow-Clinic, Berlin, Conventional endoscopic ultrasound the so-called ‘miniprobes’ into the biliary system Germany Linear versus radial systems or the pancreatic duct in order to obtain high-res- †Author for correspondence: Department of Surgery & Surgical Endoscopic ultrasound (EUS) with flex- olution radial ultrasound images locally. Present Oncology, Helios Hospital Berlin, ible endoscopes is an important diagnostic and mini probes show a diameter of 2–3 mm and oper- 13122 Berlin, Germany Tel.: +49 309 417 1480 therapeutic tool, especially for the local staging ate with frequencies between 12 and 30 MHz. Fax: +49 309 417 1404 of gastrointestinal (GI) cancers, the differen- The main drawbacks of these devices are the lim- michael.huenerbein@ tiation between benign and malignant tumors, ited durability and the decreased depth of penetra- helios-kliniken.de and interventional procedures, such as biopsies tion (~2 cm).
    [Show full text]
  • Ultrasound Elastography: Principles and Techniques
    Diagnostic and Interventional Imaging (2013) 94, 487—495 . CONTINUING EDUCATION PROGRAM: FOCUS Ultrasound elastography: Principles and techniques ∗ J.-L. Gennisson , T. Deffieux, M. Fink, M. Tanter Institut Langevin, ondes et images [Waves and Images], ESPCI ParisTech, CNRS UMR 7587, Inserm ERL U979, université Paris VII, 1, rue Jussieu, 75238 Paris cedex 05, France KEYWORDS Abstract Ultrasonography has been widely used for diagnosis since it was first introduced Ultrasound in clinical practice in the 1970’s. Since then, new ultrasound modalities have been developed, elastography; such as Doppler imaging, which provides new information for diagnosis. Elastography was devel- Quasi-static method; oped in the 1990’s to map tissue stiffness, and reproduces/replaces the palpation performed Dynamic method; by clinicians. In this paper, we introduce the principles of elastography and give a technical Impulse summary for the main elastography techniques: from quasi-static methods that require a static elastography; compression of the tissue to dynamic methods that uses the propagation of mechanical waves Shear wave in the body. Several dynamic methods are discussed: vibro-acoustography, Acoustic Radiation elastography Force Impulsion (ARFI), transient elastography, shear wave imaging, etc. This paper aims to help the reader at understanding the differences between the different methods of this promising imaging modality that may become a significant tool in medical imaging. © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved. Ultrasonography is a widely used medical imaging technique with many clinical appli- cations. Used in clinical practice for more than 40 years, it is highly regarded for its ease of use, real-time capability, portability and low cost.
    [Show full text]
  • Cigna Medical Coverage Policies – Radiology Neck Imaging Effective November 15, 2018
    Cigna Medical Coverage Policies – Radiology Neck Imaging Effective November 15, 2018 ______________________________________________________________________________________ Instructions for use The following coverage policy applies to health benefit plans administered by Cigna. Coverage policies are intended to provide guidance in interpreting certain standard Cigna benefit plans and are used by medical directors and other health care professionals in making medical necessity and other coverage determinations. Please note the terms of a customer’s particular benefit plan document may differ significantly from the standard benefit plans upon which these coverage policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a coverage policy. In the event of a conflict, a customer’s benefit plan document always supersedes the information in the coverage policy. In the absence of federal or state coverage mandates, benefits are ultimately determined by the terms of the applicable benefit plan document. Coverage determinations in each specific instance require consideration of: 1. The terms of the applicable benefit plan document in effect on the date of service 2. Any applicable laws and regulations 3. Any relevant collateral source materials including coverage policies 4. The specific facts of the particular situation Coverage policies relate exclusively to the administration of health benefit plans. Coverage policies are not recommendations for treatment and should never be used as treatment guidelines. This evidence-based medical coverage policy has been developed by eviCore, Inc. Some information in this coverage policy may not apply to all benefit plans administered by Cigna. These guidelines include procedures eviCore does not review for Cigna.
    [Show full text]
  • Endoscopic Ultrasound: What Is It and When Should It Be Used?
    CMJ0906-Willert.qxd 11/10/09 7:54 PM Page 539 ■ CLINICAL PRACTICE Clinical Medicine 2009, Vol 9, No 6: 539–43 Endoscopic ultrasound: what is it and when should it be used? Yogananda Reddy and Robert P Willert ABSTRACT – Endoscopic ultrasound (EUS) is an increasingly There are two types of commonly used echoendoscopes each available diagnostic and therapeutic tool used within the UK. with differing characteristics. Radial EUS was the first to be It has wide applications both in the gastrointestinal tract and developed and provides a 360-degree view in a plane perpendic- mediastinum with its current main uses being in the staging ular to that of the scope, similar to a computed tomography (CT) of luminal malignancies and assessment of pancreatic and image (Fig 2). Linear EUS provides a localised oblique image subepithelial lesions. The emergence of linear EUS has parallel to the scope and enables therapeutic intervention under opened up new therapeutic avenues with fine needle aspira- ultrasound (Fig 3). High frequency EUS mini-probes are also tion, trucut biopsies, coeliac plexus blocks and transmural available which can be passed down a standard biopsy channel of pseudocyst drainage all now possible. Future developments an endoscope in cases where strictures cannot be passed using a include localised brachytherapy/chemotherapy and alcohol standard EUS scope. ablation of unresectable pancreatic malignancies and EUS- guided endoscopic surgery. Indications for endoscopic ultrasound KEY WORDS: cancer staging, endoscopic ultrasound, fine The indications for EUS can be divided into several categories: needle aspiration • staging of GI malignancies • evaluating pancreaticobiliary disease Introduction • evaluating subepithelial abnormalities • evaluating extraluminal abnormalities Endoscopic ultrasound (EUS) was developed in the 1980s • staging of lung cancer but was rarely used within most of the UK.
    [Show full text]
  • Coronary Sinus Cryoablation of Ventricular Tachycardia After Failed Radiofrequency Ablation
    www.symbiosisonline.org Symbiosis www.symbiosisonlinepublishing.com Case Report Journal of Clinical Trials in Cardiology Open Access Coronary Sinus Cryoablation of Ventricular Tachycardia after Failed Radiofrequency Ablation Jiménez-Fernández M*, Macías- Ruiz R, Álvarez-López M, and Tercedor- Sánchez L Virgen de las Nieves University Hospital, Granada, Spain Received: March 11, 2014; Accepted: September 10, 2014; Published: September 25, 2014 *Corresponding author: Miriam Jiménez-Fernández, Virgen de las Nieves University Hospital, Granada, Spain, E-mail: [email protected] Abstract We present a case of Great Cardiac Vein (GCV) cryoablation in order to suppress idiopathic epicardial Ventricular Tachycardia (VT) after failed Radiofrequency (RF) ablation via the epicardium and GCV. RF ablation is the technique of choice for the treatment of Ventricular Arrhythmias (VA). However, this procedure has its limitations when delivered inside the distal cardiac veins. Cryoablation is a good alternative in patients where RF cannot be used because of risk of high impedance. Keywords: Percutaneous epicardial ablation; Ventricular tachycardia; Radiofrequency; Catheter ablation; Cryoablation; Coronary sinus; High impedance; Cryoenergy; Great cardiac vein; Mapping; Electroanatomic mapping system; 12-lead surface electrocardiogram Case Report tachycardia, but the delivery of RF had to be interrupted with a maximal energy of 15 W, as the impedance rise exceeded the A 56-year-old female patient presented in emergency room referring shortness of breath and chest pain. ECG showed we decided to change to a 6 mm tip cryoablation catheter that was sustained monomorphic VT at 160 beats per minute with right ablesafety to limit reach (>300 the programmed Ω) (Figure 1C). temperature In order to of solve -80°C this suppressing problem, bundle branch block and right inferior axis morphology (Figure the VT with no further recurrences.
    [Show full text]
  • Ultrasound Elastography in Musculoskeletal Radiology: Past, Present, and Future
    156 Ultrasound Elastography in Musculoskeletal Radiology: Past, Present, and Future Žiga Snoj, MD, PhD1,2 C. H. Wu, MD3 M.S. Taljanovic, MD4 I. Dumić-Čule, MD5 E. E. Drakonaki, MD6 Andrea S. Klauser, MD7 1 Radiology Institute, University Medical Centre Ljubljana, Ljubljana, Address for correspondence Žiga Snoj, MD, PhD, Radiology Institute, Slovenia University Medical Centre Ljubljana, Ljubljana, Slovenia 2 Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia (e-mail: [email protected]). 3 Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital College of Medicine, National Taiwan University, Taipei, Taiwan 4 Department of Medical Imaging, University of Arizona, Business, SimonMed Imaging, Scottsdale, Arizona 5 Department of Diagnostic and Interventional Radiology, University Hospital, Zagreb, Croatia 6 Medical School of the European University, Cyprus 7 Department of Radiology, Division of Rheumatology and Sports Imaging, Medical University Innsbruck, Innsbruck, Austria Semin Musculoskelet Radiol 2020;24:156–166. Abstract Ultrasound elastography (USE) is becoming an important adjunct tool in the evaluation of various musculoskeletal (MSK) traumatic conditions and diseases, with an increasing number of applications and publications in recent years. This rapidly evolving technique enhances the conventional ultrasound (US) examination by providing information on the elastic properties of tissue alongside the morphological and Keywords vascular information obtained from B-mode US and Doppler imaging. Those perform- ► ultrasound ing USE must have basic knowledge of its proper imaging techniques and limitations. In ► elastography this review article, we place the USE in historical perspective and discuss basic ► musculoskeletal techniques and current applications of USE in the evaluation of various traumatic ► quantitative imaging and pathologic conditions of fasciae, nerves, muscles, tendons, ligaments, and MSK ► shear deformation soft tissue masses.
    [Show full text]